Physician profile
Kellie Pack
NPI 1336542943
$2,587.86
in general payments reported to CMS, 2019-2025
27 companies · $621 in 2025
The $621 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $458 · 2022: $444 · 2023: $703 · 2024: $361 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,585 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.96 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $439.02 | 2021-2023 | |
| Astellas Pharma US INC | $418.42 | 2021-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $388.64 | 2021-2025 | |
| Organon LLC | $233.78 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $143.12 | 2021-2025 | |
| Biogen, INC. | $140.28 | 2024-2025 | Zurzuvae |
| Medtronic, INC. | $119.30 | 2024-2025 | Interstim |
| Evofem Biosciences, INC. | $113.06 | 2021-2025 | Phexxi, Solosec, Phexx |
| Myovant Sciences INC. | $95.51 | 2021-2022 | |
| Axonics, INC. | $52.24 | 2022-2023 | Bulkamid, Axonics |
| Pfizer INC. | $45.65 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.13 | 2021 | |
| Avion Pharmaceuticals | $38.94 | 2021-2023 | Balcoltra |
| Exeltis, USA INC. | $36.03 | 2023-2025 | Slynd |
| Optumhealth Care Solutions, LLC | $35.35 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.87 | 2022 | |
| Sumitomo Pharma America, INC. | $28.96 | 2024-2025 | Myfembree |
| Therapeuticsmd, INC. | $27.16 | 2021 | |
| Daiichi Sankyo INC. | $23.66 | 2023 | Injectafer |
| Gynesonics, INC. | $22.14 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bausch Health US, LLC | $20.69 | 2022 | |
| Agile Therapeutics, INC. | $20.54 | 2023 | Twirla |
| Exact Sciences Corporation | $15.22 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $14.25 | 2023 | |
| Shield Therapeutics INC | $13.86 | 2023 | Accrufer |
| Olympus America INC. | $13.17 | 2023 | Olympus |
| Merck Sharp & Dohme LLC | $12.87 | 2023 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Pack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.